Tuberculosis remains a public health crisis. The World Health Organization's Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Health workers in developing countries know that isolating tuberculosis patients is an outdated and potentially harmful practice, but lack the resources to move away from it.

Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the ...

Treating all household contacts of someone with tuberculosis (TB) helped prevent active TB disease across age groups in the real world, but the effectiveness was highest when treating individuals who ...

Sepsis is a leading global cause of hospital deaths, occurring when the body’s response to infection damages tissue and causes organs to fail. Africa bears the world’s highest burden of sepsis, with ...

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and causes organs to fail. Africa bears the world's highest burden of sepsis, with ...

Tuberculosis (TB) may last for several months, with treatment. The length of time it takes to cure the condition can vary. It may depend on whether the TB is latent or active. Tuberculosis (TB) is a ...